NCT04228419

Brief Summary

This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
81mo left

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Mar 2020Dec 2032

First Submitted

Initial submission to the registry

December 17, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 14, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

March 9, 2020

Completed
9.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

9.8 years

First QC Date

December 17, 2019

Last Update Submit

March 21, 2025

Conditions

Keywords

arthroplastyglenohumeral osteoarthritisidiopathic osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Western Ontario Osteoarthritis of the Shoulder Index (WOOS)

    The Western Ontario Osteoarthritis of the Shoulder Index (WOOS) is a disease specific evaluation, proven to be an accurate and valid assessment of function after shoulder replacement. The WOOS is a patient-reported measure, 19-question survey. Each question is measured using a visual analog scale rated from 0-100, where higher scores mean better outcome.

    24-Months and 5-Years Post-Operative

Secondary Outcomes (8)

  • Standard CT Scans

    24-Months and 5-Years Post-Operative

  • American Shoulder and Elbow Surgeons Standardized Shoulder Assessment form (ASES)

    24-Months and 5-Years Post-Operative

  • Pain Level

    24-Months and 5-Years Post-Operative

  • Subjective Shoulder Value

    24-Months and 5-Years Post-Operative

  • EuroQol EQ-5D-5L

    24-Months and 5-Years Post-Operative

  • +3 more secondary outcomes

Study Arms (2)

Total Shoulder Arthroplasty (anatomic)

ACTIVE COMPARATOR

TSA procedure involves replacing the worn-out ball and socket joint with prosthetic components.

Procedure: Total Shoulder Arthroplasty

Reverse Shoulder Arthroplasty

ACTIVE COMPARATOR

RSA procedure is similar to a TSA, however the orientation of the ball and socket joint is placed in the reverse position

Procedure: Reverse Shoulder Arthroplasty

Interventions

Replacement of the shoulder joint (ball and socket, or humeral head and glenoid) using prosthetic components.

Total Shoulder Arthroplasty (anatomic)

Replacement of the shoulder joint like the TSA, however the orientation of the ball and socket is reversed.

Reverse Shoulder Arthroplasty

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:
  • The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
  • Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
  • Activity modification
  • Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
  • Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
  • years of age and older

You may not qualify if:

  • Active joint or systemic infection
  • Rotator cuff arthropathy
  • Significant muscle paralysis
  • Charcot's arthropathy
  • Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
  • Unable to understand the consent form/process
  • Pregnancy
  • Psychiatric illness that precludes informed consent
  • Unwilling to be followed for the duration of the study
  • Retroversion cannot be surgically corrected to within 10 degrees of neutral
  • History of previous shoulder surgery on affected side

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Alberta

Edmonton, Alberta, T6G2G3, Canada

NOT YET RECRUITING

Pan Am Clinic Foundation

Winnipeg, Manitoba, R3M3E4, Canada

NOT YET RECRUITING

Kingston General Hospital (Site-Watkins 3)

Kingston, Ontario, K7L 2V7, Canada

RECRUITING

The Ottawa Hospital

Ottawa, Ontario, K1H8L6, Canada

RECRUITING

MeSH Terms

Interventions

Arthroplasty, Replacement, Shoulder

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Peter Lapner, MD

    The Ottawa Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Lapner Lapner, MD

CONTACT

Katie McIlquham

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2019

First Posted

January 14, 2020

Study Start

March 9, 2020

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

December 31, 2032

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

IPD will not be shared with other researchers, who are not participating in the study.

Locations